Background: There are significant racial and socioeconomic disparities in health outcomes for patients with type 1 diabetes (T1D) . COVID-also disproportionately affected racial/ethnic minority groups.

Objective: We examined whether the pandemic differentially impacted patients with T1D who identified as minority (Hispanic, non-Hispanic Black, Asian) versus non-minority (non-Hispanic white) .

Methods: We administered the COVID-Exposure and Family Impact Survey to adolescents with T1D seen at the NYU Pediatric Diabetes Center from May 2020 - May 2021 (n=165) . Patient characteristics were compared using chi-square tests and linear regression models.

Results: Respondents (n=41) had a median age of 17 years (range 15-23, SD 2.2) . Most respondents identified as non-minority (58.5%) , female (53.7%) , and were privately insured (65.9%) . Those identifying as minority had higher distress scores (5.4 versus 3.9; p=.07) , less continuous glucose monitor use, and higher HbA1c levels compared to non-minority patients (p<0.05) . Higher distress scores were associated with lower family income and worse family dynamics (p<0.05) . Distress was also related to worse health behaviors, including reduced exercise, poor eating habits, and impaired sleep. Notably, impaired sleep was also associated with higher HbA1c levels (p<0.05) .

Conclusion: Adolescents with T1D who identified as minority race reported a greater impact of the COVID-pandemic on their physical and psychosocial functioning compared to their non-minority peers. Further study may identify how to mitigate these worse outcomes.


M.Goldberg: None. J.Ilkowitz: None. J.E.Gonzalez: None. C.R.Stein: None. M.Gallagher: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at